Abstract
The National Institute for Health and Care Excellence guidelines advise stopping immunosuppressive drugs for confirmed or suspected COVID-19 patients with autoimmune and inflammatory disorders. This may not be in the patient's best interest, given the potential long-term consequences of not managing chronic conditions, and immunosuppression may even be protective in those affected with COVID-19.
MeSH terms
-
Betacoronavirus
-
COVID-19
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / immunology*
-
Coronavirus Infections / physiopathology
-
Cytokine Release Syndrome / immunology*
-
Deprescriptions*
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Pandemics
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / immunology*
-
Pneumonia, Viral / physiopathology
-
Practice Guidelines as Topic
-
Prognosis
-
SARS-CoV-2
-
Severity of Illness Index
-
United Kingdom / epidemiology